re: Ann: Neuren announces cancer xenograft te... The thing to remember is that the enemy of all small Biotech companies is time and money. And due to the sloppiness of their study NEU just burnt through cash and wasted time.
I hope they are looking through their test procedure for other and future trials and are doing QC on all materials etc being supplied by external parties
Ann: Neuren announces cancer xenograft testing re, page-47
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.57 | 1717 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |